Total Funding
63
64
Total FundingVenture - Series Unknown raised
Growth Score
-28 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85474
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
- Robert E. Hurst: Vice President for Urologic Research
- Thomas H. Jozefiak: Co-Founder & Chief Scientific OfficerPast Role: Genzyme, VP, Biomaterials Science & Engineering
About the Company
Glycologix is a biotechnology company that focuses on locally delivered biopolymers for soft tissue protection. Replenishing naturally occurring proteoglycans can help with a variety of unmet medical conditions. Its platform discovery engine makes it possible to create synthetic structural mimics of proteoglycans. These novel materials are highly
soluble despite their high molecular weight, allowing for optimal tissue coverage. Interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair are among the platform's targeted indications.
